UK markets closed
  • NIKKEI 225

    28,884.13
    +873.20 (+3.12%)
     
  • HANG SENG

    28,309.76
    -179.24 (-0.63%)
     
  • CRUDE OIL

    73.08
    -0.58 (-0.79%)
     
  • GOLD FUTURES

    1,776.40
    -6.50 (-0.36%)
     
  • DOW

    33,945.58
    +68.61 (+0.20%)
     
  • BTC-GBP

    23,307.15
    -140.88 (-0.60%)
     
  • CMC Crypto 200

    772.86
    -21.46 (-2.70%)
     
  • ^IXIC

    14,253.27
    +111.79 (+0.79%)
     
  • ^FTAS

    4,046.87
    +19.91 (+0.49%)
     

Aladdin Healthcare Technologies SE reports the sale of software and intellectual property

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
  • Oops!
    Something went wrong.
    Please try again later.

Aladdin Healthcare Technologies SE / Key word(s): Disposal
Aladdin Healthcare Technologies SE reports the sale of software and intellectual property

18-May-2021 / 12:46 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Aladdin Healthcare Technologies SE reports the sale of software and intellectual property

BERLIN/LONDON, 18 May 2021 - Aladdin Healthcare Technologies SE (the "Company") reports that its 100% subsidiary Aladdin Healthcare Technologies Ltd ("Aladdin Ltd") has today completed the sale of specific software and intellectual property to a customer based in the People's Republic of China. As consideration for the sale, the customer has paid GBP 500,000 to Aladdin Ltd.

Aladdin Ltd has developed and is developing various AI-driven technology products for the healthcare market. It has developed prototype AI-driven Drug Discovery Platform and Knowledge Graph which can be tailored to various areas of drug development. The software being sold is the above-described intellectual property but specifically to be used for small molecule drug discovery in the area of Alzheimer's and Dementia. Aladdin retains the rights to use it in other areas.

Wade Menpes-Smith

Contact:
Aladdin Healthcare Technologies SE
Unter den Linden 10
10117 Berlin
Tel 030 7700 140 449
email: info@aladdinid.com
www.aladdinid.com

18-May-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

Aladdin Healthcare Technologies SE

Unter den Linden 10

10117 Berlin

Germany

Phone:

030 700140449

E-mail:

info@aladdinid.com

Internet:

www.aladdinid.com

ISIN:

DE000A12ULL2

WKN:

A12ULL

Listed:

Regulated Market in Dusseldorf

EQS News ID:

1197804


 

End of Announcement

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting